Aurobindo Pharma Limited (BOM:524804)
1,152.05
+13.25 (1.16%)
At close: Jul 15, 2025
Aurobindo Pharma Market Cap
Aurobindo Pharma has a market cap or net worth of 669.08 billion as of July 15, 2025. Its market cap has decreased by -3.90% in one year.
Market Cap
669.08B
Enterprise Value
669.29B
Revenue
317.24B
Ranking
n/a
PE Ratio
19.19
Stock Price
1,152.05
Market Cap Chart
Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 669.08B, an increase of 6,867.24%. That is a compound annual growth rate of 20.21%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 15, 2025 | 669.08B | -13.68% |
Dec 31, 2024 | 775.08B | 22.03% |
Dec 29, 2023 | 635.16B | 147.32% |
Dec 30, 2022 | 256.82B | -40.31% |
Dec 31, 2021 | 430.28B | -20.29% |
Dec 31, 2020 | 539.83B | 101.66% |
Dec 31, 2019 | Pro | Pro |
Dec 31, 2018 | Pro | Pro |
Dec 29, 2017 | Pro | Pro |
Dec 30, 2016 | Pro | Pro |
Dec 31, 2015 | Pro | Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Reliance Industries | 18.85T |
HDFC Bank | 15.21T |
Tata Consultancy Services | 11.66T |
Bharti Airtel | 11.53T |
ICICI Bank | 10.16T |
State Bank of India | 7,218.68B |
Infosys | 6,508.29B |
Hindustan Unilever | 5,912.98B |